Archive for 'January,2014'

Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round

Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round

Bioxodes SA, (Marche-en-Famenne, Belgium) a company developing products derived from natural sources, has completed a €2.6 million ($3.5 million) seed funding round thanks to a consortium of business angels and Belgian investment funds. €1.6 million of [...]

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

The first European Advanced Therapies Investor Day began with the sound of  the “opening bell” of the Euronext stock market (Brussels) resonating the potential of the rapidly expanding sector of advanced therapies. Watch ceremony For the [...]

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences SA has announced that it has received €4.0 million of non-dilutive funding from the Walloon Region through the conclusion of a new recoverable cash advance (RCA) granted for an amount of €2.5 million and [...]

XFFLEXX bets on cryotherapy to tackle the leading cause of death in the world

XFFLEXX bets on cryotherapy to tackle the leading cause of death in the world

XFFLEXX, located in Liège (Belgium),  is developing CRYO MORPHOTM, an innovative technology based on early therapeutic hypothermia (cryotherapy) aimed at reducing the neurological damage risks for patients suffering from cardiorespiratory arrest and cerebral vascular accidents. Today, XFFLEXX is [...]